×

Stocks Amgen Inc

  • Stocks rose Tuesday as global stimulative measures reassured investors that governments were taking steps against economic weakness. Bill Smead, CEO and CIO of Smead Capital Management and Ryan Detrick, Chief Technical Strategist at Schaeffer’s Investment Research shared their best plays.

  • NYSE_building_ticker_200.jpg

    Tuesday's retail sales and the NFIB small business survey could decide whether the September rally rolls on for another day.

  • Reports that Microsoft may be planning a debt sale to pay dividends and buybacks makes perfect sense. Think of it this way: why not add leverage?

  • Midday Thoughts: What's up with September? Supposedly the worst month of the year, it's up nearly 7 percent so far.

  • Stocks closed higher after struggling to find direction much of the day amid light volume and ahead of a week filled with economic data. Chevron and Merck gained, HP fell.

  • Stocks are modestly higher after struggling to find direction much of the day amid light volume and ahead of a week filled with economic data. Merck and Chevron gained, HP fell.

  • Stocks ended higher amid light volume for a second straight day Thursday following a pair of upbeat economic reports. Adobe jumped, McDonald's slipped.

  • Stocks rose modestly in light late-afternoon trading Thursday after a pair of upbeat economic reports. Adobe jumped, McDonald's slipped.

  • Stocks rose Thursday after encouraging readings on jobless claims and the trade deficit. Financials led the way, while McDonald's capped gains on the Dow.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks ended relatively flat Friday after a disappointing GDP report but the Dow logged its best month in a year, rising more than 7 percent.

  • Stocks see-sawed after economic readings on consumer sentiment and business activity offset disappointment with a lower-than-expected GDP report.

  • Outside the New York Stock Exchange in lower Manhattan.

    Stocks head into the final day of July with the best monthly gain in a year, yet July's hot performance has only sparked debate about what August will bring.

  • Amgen

    The biotechnology bellwether reported an improved adjusted profit of $1.38 a share. Sales rose 2 percent to $3.8 billion, against $3.71 billion a year earlier.

  • earnings_central_badge.jpg

    What follows is a roundup of corporate earnings reports for Thursday, July 29.

  • Job Losses

    Weekly jobless claims will again be a big event for Thursday's markets, and economists think the number will not really show any improvement.

  • Stocks surged Thursday with the Dow jumping at least 200 points after another strong batch of earnings reports. Sandy Lincoln, investment strategist at M&I Investment Management, and Bill Smead, CEO and CIO of Smead Capital Management, shared their insights.

  • Here's what analysts and others say they're watching before the bell Thursday.

  • 10_20_BILL.jpg

    Companies have been hoarding more cash more than ever due to concerns over a double-dip recession and uncertainties in the environment.

  • Following a poor quarterly performance for most of the major averages, investors seeking opportunities for the rest of the year may want to look at companies with the potential to weather any potential "double dips". One of the metrics that is closely watched by Wall Street is the amount of cash available.